News
Additionally, we delved into the Gene Ontology biological process (GO_BP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of PABPN1 and its coexpression genes through gene set enrichment ...
Estimates are moving higher for Herbalife (HLF). The full year 2025 has seen a big move, going from $1.74 to $1.91 over the last 30 days. 2026 saw a move higher as well, going from $2.26 to $2.30 ...
Estimates are moving higher for Herbalife (HLF). The full year 2025 has seen a big move, going from $1.74 to $1.91 over the last 30 days. 2026 saw a move higher as well, going from $2.26 to $2.30 ...
Climate Solutions A gene could be key to growing rice, and feeding billions, in a hotter world. Researchers say they can improve rice harvests and grain quality by essentially turning off a ...
Personalized gene editing saved a baby, but the tech’s future is uncertain. Costs, government regulation and lack of know-how could hinder wider use of the CRISPR tech ...
Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further innovations in safety, efficacy, and treatment strategies are needed.
Baby saved by gene-editing therapy 'graduates' from hospital, goes home. KJ Muldoon was diagnosed with a rare, deadly genetic disease after he was born. By Sony Salzman. June 4, 2025, 11:09 AM.
Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.
A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results